Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer

Human Pathology

Volumn 44, Issue 7, 2013, Pages 1365-1374

  Cho, Hanbyoul ^a,b   Kim, Jane Seon Young ^a,c   Chung, Hyunsoo ^b   Perry, Candice ^b   Lee, Heejeong ^a   Kim, Jae Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ARID1A BAF250a; Cervical cancer; Immunohistochemistry; Prognostic marker; Tissue microarray

Indexed keywords

MESSENGER RNA;

ARID1A GENE; ARTICLE; BAF250A GENE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NUCLEAR PROTEINS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84879222020     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.11.007     Document Type: Article

References (29)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. J.M. Walboomers, M.V. Jacobs, and M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
3. P.J. Eifel, K. Winter, and M. Morris Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01 J Clin Oncol 22 2004 872 880
4. R.A. Burger, B.J. Monk, and T. Kurosaki Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer J Natl Cancer Inst 88 1996 1361 1368
5. G. Delgado, B. Bundy, R. Zaino, B.U. Sevin, W.T. Creasman, and F. Major Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study Gynecol Oncol 38 1990 352 357
6. D. Herr, J. Konig, V. Heilmann, K. Koretz, R. Kreienberg, and C. Kurzeder Prognostic impact of satellite-lymphovascular space involvement in early-stage cervical cancer Ann Surg Oncol 16 2009 128 132
7. A.F. Hurlstone, I.A. Olave, N. Barker, M. van Noort, and H. Clevers Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein Biochem J 364 2002 255 264
8. J. Huang, Y.L. Zhao, Y. Li, J.A. Fletcher, and S. Xiao Genomic and functional evidence for an ARID1A tumor suppressor role Genes Chromosomes Cancer 46 2007 745 750
9. D. Reisman, S. Glaros, and E.A. Thompson The SWI/SNF complex and cancer Oncogene 28 2009 1653 1668
10. S. Jones, T.L. Wang, and M. Shih Ie Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma Science 330 2010 228 231
11. K. Wang, J. Kan, and S.T. Yuen Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer Nat Genet 43 2011 1219 1223
12. K.C. Wiegand, S.P. Shah, and O.M. Al-Agha ARID1A mutations in endometriosis-associated ovarian carcinomas N Engl J Med 363 2010 1532 1543
13. Z.J. Zang, I. Cutcutache, and S.L. Poon Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes Nat Genet 44 2012 570 574
14. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
15. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408
16. H. Oya, A. Yokoyama, and I. Yamaoka Phosphorylation of Williams syndrome transcription factor by MAPK induces a switching between two distinct chromatin remodeling complexes J Biol Chem 284 2009 32472 32482
17. A.H. Shain, C.P. Giacomini, and K. Matsukuma Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer Proc Natl Acad Sci U S A 109 2012 E252 E259
18. A. Mamo, L. Cavallone, and S. Tuzmen An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer Oncogene 31 2012 2090 2100
19. W.J. Lowery, J.M. Schildkraut, and L. Akushevich Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers Int J Gynecol Cancer 22 2012 9 14
20. B. Guan, T.L. Wang, and M. Shih Ie ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers Cancer Res 71 2011 6718 6727
21. B. Guan, T.L. Mao, and P.K. Panuganti Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma Am J Surg Pathol 35 2011 625 632
22. B.G. Wilson, and C.W. Roberts SWI/SNF nucleosome remodellers and cancer Nat Rev Cancer 11 2011 481 492
23. C.W. Roberts, and S.H. Orkin The SWI/SNF complex - chromatin and cancer Nat Rev Cancer 4 2004 133 142
24. N.G. Nagl Jr., A. Patsialou, D.S. Haines, P.B. Dallas, G.R. Beck Jr., and E. Moran The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest Cancer Res 65 2005 9236 9244
25. C.W. Roberts, M.M. Leroux, M.D. Fleming, and S.H. Orkin Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5 Cancer Cell 2 2002 415 425
26. A. Katagiri, K. Nakayama, and M.T. Rahman Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma Mod Pathol 25 2012 282 288
27. X. Zhang, Y. Zhang, and Y. Yang Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance Cancer Epidemiol 36 2012 288 293
28. A. Katagiri, K. Nakayama, and M.T. Rahman Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix Int J Gynecol Cancer 22 2012 208 212
29. K.C. Wiegand, A.F. Lee, and O.M. Al-Agha Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas J Pathol 224 2011 328 333